[1] Mi Liehan, Ke Ting, Xiao Yang, et al. On the TCM Etiology and Pathogenesis of Covid -19and Its Prevention and Treatment [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2020, (04): 30-34. [doi: 10.13424/j.cnki.jsctcm.2020.04.006]
On the TCM Etiology and Pathogenesis of Covid -19and Its Prevention and Treatment
- Article number:
- 2096-1340(2020)04-0030-05
- Keywords:
- Covid -19; the warm toxin; the lung deficiency; clear the warmness and remove the toxin; invigorate the deficiency and support the vital qi
- ZTFLH:
- R563.1
- Code:
- Ａ
- Abstract:
- Covid -19 should be categorized into the warm disease in the territory of TCM, specifically it is a kind of disease which is caused by the warm virus storing in the lung. The pathogenesis of this disease comes from the exterior warm evil and the interior deficiency of pectoral qi, motivating the source of the storing evil and causing the simultaneous occurrence of diseases in the lung and spleen. The prevention is based on the theory of “ the pectoral - qi oriented” proposed by Mi liehan and his successors of the internal medicine in Chang’ an, which aims to protect the pectoral qi to improve the immunity of human body and invigorate the deficiency and support the vital qi, thus dispersing the evil. Meanwhile, the typical symptoms of Covid - 19 such as fever, fatigue, dry cough should be attached the greatest importance while regulating the transformation activity of the qi and blood in the spleen and stomach accordingly, clearing the heat of lung and moisturing its dryness to remove the dampness and toxin. Finally, the source of the disease will be cleared off.
References:
[1] World Health Organization. Novel coronavirus – China [ EB/ OL] . ( 2020 -01 -12) [ 2020 -02 -07] . https: / /www. who. int/ csr/ don/12 - january - 2020 - novel -coronavirus - china/ en.
[2]国家卫健委.新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB].(2020-02-04)[2020-02-06].
[3]李晟,李妮蓉,刘玲玲,等.新型冠状病毒肺炎的临床特征[J].基础医学与临床,2020,40(5):593-597.
[4] Huang C, Aang Y, Li X, et al. Clinical features of patients infected with 2019 novelcoronavirus in Wuhan, China.2020 - 01 - 24. dol: https/ / doi. org/10. 1016/ s0140 -6736( 20) 30183 -5.
[5]毛得宏,李玲珑,张锋.基于“邪伏膜原”探讨中医药防治新型冠状病毒肺炎方案[J].中国中医急症,2020,29(6):944-948.
[6]谢怡琼,王琪瑞,孙思雅,等.灵芝的药理作用和临床应用研究进展[J].临床医学研究与实践,2020,5(4):191-193.
Memo
基金项目:国家中医药管理局首批中医学术流派传承建设项目-长安米氏内科流派传承工作室建设项目(LPGZS2012-59);长安米氏内科流派第二轮建设项目